Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma, Radiotherapy, Sorafenib”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Early research (Phase 1)WithdrawnNCT01801163
What this trial is testing

A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Indiana University
Not applicableEnded earlyNCT01141478
What this trial is testing

Proton Radiotherapy Plus Sorafenib Versus Sorafenib for Patients With HCC Exceeding San Francisco Criteria

Who this might be right for
Carcinoma, Hepatocellular
Loma Linda University 8
Large-scale testing (Phase 3)UnknownNCT01135056
What this trial is testing

Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Singapore General Hospital 360
Large-scale testing (Phase 3)Study completedNCT01730937
What this trial is testing

Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
Radiation Therapy Oncology Group 193
Testing effectiveness (Phase 2)Study completedNCT03535259
What this trial is testing

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, Radiotherapy, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 86
Testing effectiveness (Phase 2)UnknownNCT00999843
What this trial is testing

Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer

Who this might be right for
Hepatocellular Carcinoma
Fudan University 30
Testing effectiveness (Phase 2)Study completedNCT02425605
What this trial is testing

Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Yonsei University 47
Large-scale testing (Phase 3)Ended earlyNCT04709380
What this trial is testing

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Who this might be right for
RadiotherapyToripalimabSorafenib+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Large-scale testing (Phase 3)UnknownNCT04387695
What this trial is testing

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

Who this might be right for
Unresectable Hepatocellular CarcinomaPortal Vein Thrombosis
First Affiliated Hospital of Zhejiang University 54
Testing effectiveness (Phase 2)Study completedNCT04611165
What this trial is testing

Concurrent Nivolumab and External Beam Radiation Therapy for Patients With Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma
National Cancer Center, Korea 50
Not applicableEnded earlyNCT01005875
What this trial is testing

Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
University of Alabama at Birmingham 5
Large-scale testing (Phase 3)Study completedNCT01901692
What this trial is testing

Sorafenib vs.TransArterial Chemoembolization Plus RadioTherapy in Hepatocellular Carcinoma With Macrovascular Invasion

Who this might be right for
Hepatocellular Carcinoma
Asan Medical Center 90
Early research (Phase 1)WithdrawnNCT01618253
What this trial is testing

Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatoma+1 more
Medical College of Wisconsin
Not applicableUnknownNCT01319942
What this trial is testing

Combined Radiotherapy and Sorafenib in Patients With Hepatoma

Who this might be right for
Hepatocellular Carcinoma
China Medical University Hospital 45
Early research (Phase 1)Study completedNCT00892658
What this trial is testing

Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 24
Early research (Phase 1)WithdrawnNCT02989870
What this trial is testing

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Who this might be right for
HepatoCellular CarcinomaUnresectable HepatoCellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute
Not applicableUnknownNCT01328223
What this trial is testing

Study of Combined Sorafenib With Radiotherapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
China Medical University Hospital 45